상세 보기
Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial
- Park, J. -W.;
- Kim, Y. J.;
- Kim, D. Y.;
- Bae, S. H.;
- Paik, S. W.;
- ... Yeon, J. E.;
- 외 8명
Citations
WEB OF SCIENCE
5- 제목
- Sorafenib with versus without concurrent conventional transarterial chemoembolization (cTACE) in patients with advanced hepatocellular carcinoma (HCC): Results from a multicenter, open-label, randomized, controlled phase III STAH trial
- 저자
- Park, J. -W.; Kim, Y. J.; Kim, D. Y.; Bae, S. H.; Paik, S. W.; Lee, Y. -J.; Lee, D.; Lee, H. C.; Han, S. Y.; Cheong, J. Y.; Kwon, O. S.; Yeon, J. E.; Kim, B. H.; Hwang, J. -S.
- 발행일
- 2018-04
- 유형
- Meeting Abstract
- 권
- 68
- 페이지
- S2 ~ S2
- 언어
- ENG
- 출판사
- ELSEVIER SCIENCE BV
- 발행국가
- 네덜란드
- ISSN
- E 1600-0641
P 0168-8278